+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Data At Heart Rhythm 2023 Highlight Key Boston Scientific Therapies is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Data At Heart Rhythm 2023 Highlight Key Boston Scientific Therapies | RobinsPost News & Noticias

Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies


MARLBOROUGH, Mass., May 20, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's key electrophysiology and cardiac rhythm management ... Read More

Late-breaking data presented at AF Symposium 2025 highlight key Boston ...


MARLBOROUGH, Mass., Jan. 16, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting the use of the FARAPULSE ™ Pulsed Field Ablation (PFA) System* and the ... Read More

Boston Scientific gets expanded PFA label for persistent AFib


Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible for treatment with the Farapulse pulsed field ablation system. Read More

Boston Scientific: evolving the cardiac rhythm management space - MSN


With its pulsed-field ablation system approved in the EU and US, Boston Scientific aims to lead the pack in atrial fibrillation treatment. Read More

Late-breaking data presented at AF Symposium 2025 highlight key Boston ...


Boston Scientific Corporation (NYSE: BSX) today announced data supporting the use of the FARAPULSE™ Pulsed Field Ablation (PFA) System* and the WATCHMAN FLX™ Left Atrial Appendage Closure ... Read More

Late-breaking data presented at AF Symposium 2025 highlight key Boston ...


Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation Published Jan 16, 2025 5:33pm EST ... Read More

Late-breaking data presented at AF Symposium 2025 highlight key Boston ...


Boston Scientific Corporation (NYSE: BSX) today announced data supporting the use of the FARAPULSE™ Pulsed Field Ablation (PFA) System* and the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus